Neuronetics (STIM) Stock Forecast, Price Target & Predictions
STIM Stock Forecast
Neuronetics stock forecast is as follows: an average price target of $8.00 (represents a 925.64% upside from STIM’s last price of $0.78) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
STIM Price Target
The average price target for Neuronetics (STIM) is $8.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $8.00 to $8.00. This represents a potential 925.64% upside from STIM's last price of $0.78.
STIM Analyst Ratings
According to 3 Wall Street analysts, Neuronetics's rating consensus is 'Buy'. The analyst rating breakdown for STIM stock is 0 'Strong Buy' (0.00%), 2 'Buy' (66.67%), 1 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Neuronetics Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 08, 2022 | Adam Maeder | Piper Sandler | $8.00 | $3.71 | 115.63% | 925.64% |
The latest Neuronetics stock forecast, released on Nov 08, 2022 by Adam Maeder from Piper Sandler, set a price target of $8.00, which represents a 115.63% increase from the stock price at the time of the forecast ($3.71), and a 925.64% increase from STIM last price ($0.78).
Neuronetics Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $0.78 | $0.78 | $0.78 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Neuronetics stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Neuronetics's last price of $0.78. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 14, 2024 | JMP Securities | Outperform | Outperform | Hold |
| Aug 12, 2024 | William Blair | Outperform | Market Perform | Downgrade |
| May 14, 2024 | William Blair | - | Outperform | Upgrade |
| Jan 09, 2023 | Piper Sandler | Overweight | Overweight | Hold |
Neuronetics's last stock rating was published by JMP Securities on Aug 14, 2024. The company gave STIM a "Outperform" rating, the same as its previous rate.
Neuronetics Financial Forecast
Neuronetics Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $20.31M | $17.88M | $17.61M | $15.54M | $18.20M | $16.50M | $16.33M | $14.18M | - | $13.80M | $14.20M | $12.29M | $15.58M | $12.45M | $9.74M | $11.48M | $17.36M | $16.00M | $16.57M | $12.73M | $13.25M |
| Avg Forecast | $25.80M | $21.87M | $20.12M | $19.59M | $24.90M | $19.14M | $18.65M | $17.12M | $19.85M | $17.58M | $17.36M | $15.18M | $16.82M | $15.02M | $15.46M | $13.46M | $14.44M | $14.10M | $14.72M | $11.57M | $14.41M | $11.23M | $8.22M | $13.03M | $16.95M | $16.19M | $15.80M | $12.69M | $410.62M |
| High Forecast | $26.21M | $22.21M | $20.44M | $19.90M | $25.29M | $19.28M | $18.94M | $17.39M | $19.97M | $17.85M | $17.63M | $15.42M | $17.08M | $15.25M | $15.63M | $13.61M | $14.59M | $14.25M | $14.88M | $11.70M | $14.56M | $11.35M | $8.31M | $13.17M | $17.13M | $16.37M | $15.98M | $12.83M | $492.75M |
| Low Forecast | $25.63M | $21.72M | $19.99M | $19.46M | $24.73M | $19.00M | $18.52M | $17.01M | $19.72M | $17.46M | $17.24M | $15.08M | $16.70M | $14.91M | $15.35M | $13.37M | $14.34M | $14.00M | $14.62M | $11.49M | $14.31M | $11.15M | $8.16M | $12.94M | $16.83M | $16.08M | $15.70M | $12.60M | $328.50M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | 5 | 5 | 9 | 6 | 4 | 4 | 7 | 4 | 11 |
| Surprise % | - | - | - | - | - | - | - | - | 1.02% | 1.02% | 1.01% | 1.02% | 1.08% | 1.10% | 1.06% | 1.05% | - | 0.98% | 0.96% | 1.06% | 1.08% | 1.11% | 1.19% | 0.88% | 1.02% | 0.99% | 1.05% | 1.00% | 0.03% |
Neuronetics's average Quarter revenue forecast for Mar 24 based on 1 analysts is $17.12M, with a low forecast of $17.01M, and a high forecast of $17.39M. STIM's average Quarter revenue forecast represents a -15.71% decrease compared to the company's last Quarter revenue of $20.31M (Dec 23).
Neuronetics EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | 5 | 5 | 9 | 6 | 4 | 4 | 7 | 4 | 11 |
| EBITDA | - | - | - | - | - | - | - | - | $-4.43M | $-8.87M | $-7.35M | $-8.75M | $-7.08M | $-6.16M | $-9.42M | $-9.54M | $-9.58M | $-6.94M | $-6.28M | $-6.62M | $-6.35M | $-2.21M | $-6.55M | $-10.79M | $-6.35M | $-5.63M | $-5.91M | $-6.41M | $-6.27M |
| Avg Forecast | $-11.18M | $-9.48M | $-8.72M | $-8.49M | $-10.79M | $-8.29M | $-8.08M | $-7.42M | $-8.60M | $-7.62M | $-7.52M | $-6.58M | $-7.29M | $-6.51M | $-6.70M | $-5.83M | $-6.26M | $-6.11M | $-6.38M | $-6.62M | $-6.24M | $-4.87M | $-3.56M | $-6.90M | $-7.34M | $-7.02M | $-6.85M | $-6.09M | $-194.34M |
| High Forecast | $-11.11M | $-9.41M | $-8.66M | $-8.43M | $-10.72M | $-8.23M | $-8.03M | $-7.37M | $-8.55M | $-7.57M | $-7.47M | $-6.53M | $-7.24M | $-6.46M | $-6.65M | $-5.79M | $-6.22M | $-6.07M | $-6.34M | $-5.29M | $-6.20M | $-4.83M | $-3.54M | $-5.52M | $-7.30M | $-6.97M | $-6.80M | $-4.87M | $-155.47M |
| Low Forecast | $-11.36M | $-9.63M | $-8.86M | $-8.62M | $-10.96M | $-8.35M | $-8.21M | $-7.54M | $-8.66M | $-7.74M | $-7.64M | $-6.68M | $-7.40M | $-6.61M | $-6.77M | $-5.90M | $-6.33M | $-6.18M | $-6.45M | $-7.94M | $-6.31M | $-4.92M | $-3.60M | $-8.29M | $-7.43M | $-7.09M | $-6.92M | $-7.30M | $-233.21M |
| Surprise % | - | - | - | - | - | - | - | - | 0.51% | 1.16% | 0.98% | 1.33% | 0.97% | 0.95% | 1.41% | 1.64% | 1.53% | 1.14% | 0.98% | 1.00% | 1.02% | 0.45% | 1.84% | 1.56% | 0.86% | 0.80% | 0.86% | 1.05% | 0.03% |
undefined analysts predict STIM's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Neuronetics's previous annual EBITDA (undefined) of $NaN.
Neuronetics Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | 5 | 5 | 9 | 6 | 4 | 4 | 7 | 4 | 11 |
| Net Income | - | - | - | - | - | - | - | - | $-5.38M | $-9.39M | $-4.90M | $-11.13M | $-8.85M | $-7.76M | $-11.05M | $-11.54M | $-7.63M | $-8.15M | $-7.53M | $-7.88M | $-3.66M | $-3.42M | $-7.76M | $-12.61M | $-7.55M | $-6.87M | $-7.09M | $-7.53M | $-7.50M |
| Avg Forecast | $-2.05M | $-4.70M | $-5.95M | $-6.14M | $-2.00M | $-6.86M | $-8.09M | $-9.30M | $-7.79M | $-9.32M | $-10.44M | $-11.65M | $-11.41M | $-12.69M | $-12.35M | $-12.04M | $-9.52M | $-9.09M | $-7.21M | $-7.88M | $-7.24M | $-8.47M | $-15.54M | $-8.07M | $-13.26M | $-12.86M | $-12.21M | $-7.15M | $-232.27M |
| High Forecast | $-2.03M | $-4.66M | $-5.90M | $-6.09M | $-1.98M | $-5.96M | $-8.02M | $-9.22M | $-7.49M | $-9.23M | $-10.35M | $-11.54M | $-11.31M | $-12.58M | $-12.24M | $-11.94M | $-9.44M | $-9.01M | $-7.14M | $-6.30M | $-7.17M | $-8.40M | $-15.41M | $-6.46M | $-13.14M | $-12.75M | $-12.10M | $-5.72M | $-185.82M |
| Low Forecast | $-2.09M | $-4.80M | $-6.07M | $-6.27M | $-2.04M | $-7.75M | $-8.26M | $-9.49M | $-8.09M | $-9.51M | $-10.66M | $-11.88M | $-11.65M | $-12.95M | $-12.53M | $-12.21M | $-9.66M | $-9.22M | $-7.31M | $-9.46M | $-7.34M | $-8.60M | $-15.76M | $-9.69M | $-13.45M | $-13.05M | $-12.38M | $-8.58M | $-278.72M |
| Surprise % | - | - | - | - | - | - | - | - | 0.69% | 1.01% | 0.47% | 0.96% | 0.78% | 0.61% | 0.89% | 0.96% | 0.80% | 0.90% | 1.04% | 1.00% | 0.51% | 0.40% | 0.50% | 1.56% | 0.57% | 0.53% | 0.58% | 1.05% | 0.03% |
Neuronetics's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. STIM's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Neuronetics SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | 5 | 5 | 9 | 6 | 4 | 4 | 7 | 4 | 11 |
| SG&A | - | - | - | - | - | - | - | - | $17.99M | $18.48M | $17.76M | $18.51M | $18.40M | $18.03M | $20.04M | $19.03M | $6.33M | $16.26M | $15.72M | $14.66M | $12.36M | $10.26M | $12.16M | $16.01M | $15.83M | $14.65M | $15.78M | $14.19M | $12.91M |
| Avg Forecast | $27.30M | $23.14M | $21.29M | $20.73M | $26.34M | $20.25M | $19.73M | $18.12M | $21.00M | $18.60M | $18.37M | $16.06M | $17.79M | $15.89M | $16.35M | $14.24M | $15.27M | $14.91M | $15.57M | $12.24M | $15.24M | $11.88M | $8.70M | $10.25M | $17.93M | $17.13M | $16.72M | $13.43M | $400.12M |
| High Forecast | $27.73M | $23.50M | $21.62M | $21.05M | $26.76M | $20.39M | $20.04M | $18.40M | $21.13M | $18.89M | $18.66M | $16.31M | $18.07M | $16.14M | $16.53M | $14.40M | $15.44M | $15.08M | $15.74M | $12.38M | $15.41M | $12.01M | $8.79M | $12.30M | $18.13M | $17.32M | $16.90M | $13.57M | $480.14M |
| Low Forecast | $27.11M | $22.98M | $21.15M | $20.58M | $26.16M | $20.10M | $19.59M | $17.99M | $20.86M | $18.47M | $18.24M | $15.95M | $17.67M | $15.78M | $16.24M | $14.14M | $15.17M | $14.81M | $15.47M | $12.16M | $15.14M | $11.80M | $8.64M | $8.20M | $17.81M | $17.01M | $16.61M | $13.33M | $320.09M |
| Surprise % | - | - | - | - | - | - | - | - | 0.86% | 0.99% | 0.97% | 1.15% | 1.03% | 1.14% | 1.23% | 1.34% | 0.41% | 1.09% | 1.01% | 1.20% | 0.81% | 0.86% | 1.40% | 1.56% | 0.88% | 0.86% | 0.94% | 1.06% | 0.03% |
Neuronetics's average Quarter SG&A projection for Mar 24 is $18.12M, based on 1 Wall Street analysts, with a range of $17.99M to $18.40M. The forecast indicates a 0.69% rise compared to STIM last annual SG&A of $17.99M (Dec 23).
Neuronetics EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | 5 | 5 | 9 | 6 | 4 | 4 | 7 | 4 | 11 |
| EPS | - | - | - | - | - | - | - | - | $-0.19 | $-0.33 | $-0.17 | $-0.40 | $-0.33 | $-0.29 | $-0.41 | $-0.43 | $-0.29 | $-0.31 | $-0.29 | $-0.31 | $-0.19 | $-0.18 | $-0.41 | $-0.68 | $-0.41 | $-0.37 | $-0.39 | $-0.42 | $-30.60 |
| Avg Forecast | $-0.07 | $-0.16 | $-0.20 | $-0.20 | $-0.07 | $-0.23 | $-0.27 | $-0.31 | $-0.26 | $-0.31 | $-0.35 | $-0.39 | $-0.38 | $-0.42 | $-0.41 | $-0.40 | $-0.32 | $-0.30 | $-0.24 | $-0.31 | $-0.24 | $-0.28 | $-0.52 | $-0.50 | $-0.44 | $-0.43 | $-0.41 | $-0.40 | $-26.03 |
| High Forecast | $-0.07 | $-0.16 | $-0.20 | $-0.20 | $-0.07 | $-0.20 | $-0.27 | $-0.31 | $-0.25 | $-0.31 | $-0.34 | $-0.38 | $-0.38 | $-0.42 | $-0.41 | $-0.40 | $-0.31 | $-0.30 | $-0.24 | $-0.31 | $-0.24 | $-0.28 | $-0.51 | $-0.50 | $-0.44 | $-0.42 | $-0.40 | $-0.40 | $-20.82 |
| Low Forecast | $-0.07 | $-0.16 | $-0.20 | $-0.21 | $-0.07 | $-0.26 | $-0.27 | $-0.32 | $-0.27 | $-0.32 | $-0.35 | $-0.40 | $-0.39 | $-0.43 | $-0.42 | $-0.41 | $-0.32 | $-0.31 | $-0.24 | $-0.31 | $-0.24 | $-0.29 | $-0.52 | $-0.51 | $-0.45 | $-0.43 | $-0.41 | $-0.41 | $-31.23 |
| Surprise % | - | - | - | - | - | - | - | - | 0.73% | 1.06% | 0.49% | 1.03% | 0.87% | 0.69% | 1.00% | 1.07% | 0.92% | 1.03% | 1.21% | 1.00% | 0.79% | 0.64% | 0.79% | 1.36% | 0.93% | 0.86% | 0.96% | 1.04% | 1.18% |
According to undefined Wall Street analysts, Neuronetics's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to STIM previous annual EPS of $NaN (undefined).
Neuronetics Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| LMDX | LumiraDx | $0.02 | $1.50 | 7400.00% | Buy |
| DRIO | DarioHealth | $0.91 | $10.75 | 1081.32% | Buy |
| STIM | Neuronetics | $0.78 | $8.00 | 925.64% | Buy |
| GTH | Genetron | $4.03 | $10.00 | 148.14% | - |
| XGN | Exagen | $2.93 | $6.00 | 104.78% | Buy |
| BDSX | Biodesix | $1.79 | $3.00 | 67.60% | Buy |
| SHC | Sotera Health Company | $16.91 | $16.93 | 0.12% | Buy |
| OLK | Olink AB (publ) | $26.08 | $21.50 | -17.56% | Hold |
STIM Forecast FAQ
Is Neuronetics a good buy?
Yes, according to 3 Wall Street analysts, Neuronetics (STIM) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 66.67% of STIM's total ratings.
What is STIM's price target?
Neuronetics (STIM) average price target is $8 with a range of $8 to $8, implying a 925.64% from its last price of $0.78. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Neuronetics stock go up soon?
According to Wall Street analysts' prediction for STIM stock, the company can go up by 925.64% (from the last price of $0.78 to the average price target of $8), up by 925.64% based on the highest stock price target, and up by 925.64% based on the lowest stock price target.
Can Neuronetics stock reach $1?
STIM's average twelve months analyst stock price target of $8 supports the claim that Neuronetics can reach $1 in the near future.
What are Neuronetics's analysts' financial forecasts?
Neuronetics's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $79.8M (high $80.89M, low $79.25M), average EBITDA is $-34.59M (high $-34.351M, low $-35.062M), average net income is $-26.246M (high $-25.181M, low $-27.536M), average SG&A $84.43M (high $85.59M, low $83.85M), and average EPS is $-0.873 (high $-0.838, low $-0.916). STIM's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $87.38M (high $88.75M, low $86.79M), average EBITDA is $-37.875M (high $-37.618M, low $-38.469M), average net income is $-18.839M (high $-18.673M, low $-19.224M), average SG&A $92.45M (high $93.9M, low $91.83M), and average EPS is $-0.627 (high $-0.621, low $-0.64).
Did the STIM's actual financial results beat the analysts' financial forecasts?
Based on Neuronetics's last annual report (Dec 2023), the company's revenue was $71.35M, beating the average analysts forecast of $69.97M by 1.97%. Apple's EBITDA was $-30.554M, beating the average prediction of $-30.327M by 0.75%. The company's net income was $-30.189M, missing the average estimation of $-39.2M by -22.99%. Apple's SG&A was $72.74M, missing the average forecast of $74.03M by -1.74%. Lastly, the company's EPS was $-1.05, missing the average prediction of $-1.304 by -19.50%. In terms of the last quarterly report (Dec 2023), Neuronetics's revenue was $20.31M, beating the average analysts' forecast of $19.85M by 2.33%. The company's EBITDA was $-4.427M, missing the average prediction of $-8.604M by -48.55%. Neuronetics's net income was $-5.377M, missing the average estimation of $-7.795M by -31.02%. The company's SG&A was $17.99M, missing the average forecast of $21M by -14.33%. Lastly, the company's EPS was $-0.19, missing the average prediction of $-0.259 by -26.75%